文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症呼吸衰竭与机械通气

院外心脏骤停昏迷幸存者预防性抗生素与临床驱动抗生素比较:一项随机先导研究

Prophylactic versus clinically-driven antibiotics in comatose survivors of out-of-hospital cardiac arrest-A randomized pilot study.
PubMed 文献 · Resuscitation · 2016-12-14
一句话结论在入院支气管镜排除气管支气管误吸的院外心脏骤停昏迷幸存者中,预防性阿莫西林-克拉维酸未显著改变全身炎症反应、复苏后肺炎、ICU治疗及结局。

该随机先导研究纳入入院支气管镜无气管支气管误吸证据的院外心脏骤停昏迷幸存者,随机分为预防性抗生素组(阿莫西林-克拉维酸1.2g每8小时一次)与临床驱动抗生素组(ICU最初7天内出现感染征象时给药)。83例入组患者中23例(28%)支气管镜记录到气管支气管误吸,最终60例随机。预防性组第3天迷你支气管肺泡灌洗培养阳性率更低(7% vs 42%,p<0.01),第6天C反应蛋白和降钙素原更低(p<0.05),但两组血管活性药物使用(均93%)、机械通气时长、气管插管时长、ICU住院时长、生存率(均73%)及神经功能良好生存(50% vs 40%)均无显著差异。

要点

  • 入院支气管镜在28%(23/83)的院外心脏骤停昏迷幸存者中记录到气管支气管误吸,误吸者未纳入随机。
  • 预防性组第3天迷你支气管肺泡灌洗培养阳性率显著低于临床驱动组(7% vs 42%,p<0.01)。
  • 预防性组第6天C反应蛋白和降钙素原低于临床驱动组(p<0.05),其余炎症指标无显著差异。
  • 两组血管活性药物使用(均93%)、机械通气时长(5.4±3.7 vs 5.2±3.1天)、ICU住院时长(7.7±5.2 vs 6.9±4.5天)无显著差异。
  • 两组生存率均为73%,神经功能良好生存率50% vs 40%,无显著差异。

适用人群与场景

  • 院外心脏骤停后昏迷幸存者,且入院支气管镜检查无气管支气管误吸证据者纳入随机。

处置流程与药物剂量

  • 预防性组:阿莫西林-克拉维酸1.2g每8小时一次。
  • 临床驱动组:ICU最初7天内出现感染征象时给予抗生素。

研究设计与关键结果

  • 随机先导研究,2013年9月至2015年2月纳入83例,其中23例(28%)支气管镜记录到气管支气管误吸,60例随机分入预防性组或临床驱动组。
  • 第1-5天使用抗生素的患者比例预防性组显著高于临床驱动组。
  • 第3天迷你支气管肺泡灌洗培养阳性率预防性组7% vs 临床驱动组42%(p<0.01)。
  • 第6天C反应蛋白和降钙素原预防性组低于临床驱动组(p<0.05),白细胞计数、CD64等其余指标无显著差异。
  • 两组血管活性药物使用均93%,机械通气时长5.4±3.7 vs 5.2±3.1天,气管插管时长6.5±4.6 vs 5.9±4.3天,ICU住院时长7.7±5.2 vs 6.9±4.5天,生存率均73%,神经功能良好生存率50% vs 40%,均无显著差异。
  • 两组肺炎X线征象累积记录均为50%。

证据类型、等级与局限

  • 证据类型:随机先导研究(ClinicalTrials.gov Identifier: NCT02899507)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:在无气管支气管误吸的院外心脏骤停昏迷幸存者中,预防性抗生素未显著改变全身炎症反应、复苏后肺炎、ICU治疗及结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To investigate benefits of prophylactic antibiotics in comatose survivors of out-of-hospital cardiac arrest (OHCA).

METHODS: Patients without evidence of tracheobronchial aspiration on admission bronchoscopy were randomized to prophylactic Amoxicillin-Clavulanic acid 1.2g every 8h (P) or clinically-driven antibiotics (C) administered if signs of infection developed during initial 7days of intensive care unit (ICU) stay.

RESULTS: Among 83 patients enrolled between September 2013 and February 2015, tracheobronchial aspiration was documented in 23 (28%). Accordingly, 60 patients were randomized. Percentage of patients on antibiotics between days 1-5 was significantly greater in P group. White blood count, C-reactive protein, procalcitonin (PCT) and CD 64 significantly increased during the postresuscitation phase. Except for lower CRP and PCT in group P on day 6 (p<0.05), there was no significant differences. Mini BAL on day 3 was less often positive in group P (7% vs. 42%; p<0.01). There was no significant difference in other microbiological samples and X-ray signs of pneumonia cumulatively documented in 50% in both groups. Use of vasopressors/inotropes (93% in both groups), duration of mechanical ventilation (5.4±3.7 vs. 5.2±3.1 days), tracheal intubation (6.5±4.6 vs. 5.9±4.3 days), ICU stay (7.7±5.2 vs. 6.9±4.5 days), survival (73% vs. 73%) and survival with good neurological outcome (50% vs. 40%) were also comparable between P and C groups.

CONCLUSION: Bronchoscopy on admission documented tracheobronchial aspiration in 28% of comatose survivors of OHCA. In the absence of aspiration, prophylactic antibiotics did not significantly alter systemic inflammatory response, postresuscitation pneumonia, ICU treatment and outcome (ClinicalTrials.gov Identifier: NCT02899507).

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Ribaric SF, Turel M, Knafelj R, et al. Prophylactic versus clinically-driven antibiotics in comatose survivors of out-of-hospital cardiac arrest-A randomized pilot study. Resuscitation. 2016. PMID: 27987397. doi:10.1016/j.resuscitation.2016.11.025

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。